Trai-ming Yeh

Tainan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

A Multivalent Dengue Fusion Protein ΔcNS1-cEDIII-ΔnNS3 Confers Cross-Serotype Protection and Durable Immunity in Mice.

A Multivalent Dengue Fusion Protein ΔcNS1-cEDIII-ΔnNS3 Confers Cross-Serotype Protection and Durable Immunity in Mice.

Journal: Journal of medical virology

Published: June 25, 2025

A non-structural protein 1 substitution of dengue virus enhances viral replication by interfering with the antiviral signaling pathway.

A non-structural protein 1 substitution of dengue virus enhances viral replication by interfering with the antiviral signaling pathway.

Journal: Journal of biomedical science

Published: September 15, 2024

Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19.

Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19.

Journal: Journal of biomedical science

Published: December 07, 2023

Dengue virus non-structural protein 1 binding to thrombin as a dengue severity marker: Comprehensive patient analysis in south Taiwan.

Dengue virus non-structural protein 1 binding to thrombin as a dengue severity marker: Comprehensive patient analysis in south Taiwan.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: September 26, 2023

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan.

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan.

Journal: Frontiers in immunology

Published: August 20, 2022

Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication.

Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication.

Journal: PLoS pathogens

Published: June 08, 2022

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.

Journal: Frontiers in immunology

Published: May 12, 2022

Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2.

Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2.

Journal: Frontiers in immunology

Published: February 03, 2022

A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.

A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.

Journal: Vaccine

Published: September 02, 2021

Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model.

Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model.

Journal: PLoS pathogens

Published: July 19, 2021

Dengue Nonstructural Protein 1 Maintains Autophagy through Retarding Caspase-Mediated Cleavage of Beclin-1.

Dengue Nonstructural Protein 1 Maintains Autophagy through Retarding Caspase-Mediated Cleavage of Beclin-1.

Journal: International journal of molecular sciences

Published: October 30, 2020

Roles of Macrophage Migration Inhibitory Factor in Dengue Pathogenesis: From Pathogenic Factor to Therapeutic Target.

Roles of Macrophage Migration Inhibitory Factor in Dengue Pathogenesis: From Pathogenic Factor to Therapeutic Target.

Journal: Microorganisms

Published: May 10, 2020

Showing 1-12 of 47

Last Updated: 09/26/2026